PURPOSE: Radiation-induced heart disease (RIHD) is a serious side-effect of thoracic radiotherapy. The epidermal growth factor receptor (EGFR) pathway is essential for the function and survival of cardiomyocytes. Hence, agents that target the EGFR pathway are cardiotoxic. Tocotrienols protect from radiation injury, but may also enhance the therapeutic effects of EGFR pathway inhibitors in cancer treatment. This study investigated the effects of local irradiation on the EGFR pathway in the heart and tests whether tocotrienols may modify radiation-induced changes in this pathway. METHODS: Male Sprague-Dawley rats received image-guided localized heart irradiation with 21 Gy. Twenty four hours before irradiation, rats received a single dose of tocotrienol-enriched formulation or vehicle by oral gavage. At time points from 2 h to 9 months after irradiation, left ventricular expression of EGFR pathway mediators was studied. RESULTS: Irradiation caused a decrease in the expression of epidermal growth factor (EGF) and neuregulin-1 (Nrg-1) mRNA from 6 h up to 10 weeks, followed by an upregulation of these ligands and the receptor erythroblastic leukemia viral oncogene homolog (ErbB)4 at 6 months. In addition, the upregulation of Nrg-1 was statistically significant up to 9 months after irradiation. A long-term upregulation of ErbB2 protein did not coincide with changes in transcription or post-translational interaction with the chaperone heat shock protein 90 (HSP90). Pretreatment with tocotrienols prevented radiation-induced changes at 2 weeks. CONCLUSIONS: Local heart irradiation causes long-term changes in the EGFR pathway. Studies have to address how radiation may interact with cardiotoxic effects of EGFR inhibitors.
PURPOSE: Radiation-induced heart disease (RIHD) is a serious side-effect of thoracic radiotherapy. The epidermal growth factor receptor (EGFR) pathway is essential for the function and survival of cardiomyocytes. Hence, agents that target the EGFR pathway are cardiotoxic. Tocotrienols protect from radiation injury, but may also enhance the therapeutic effects of EGFR pathway inhibitors in cancer treatment. This study investigated the effects of local irradiation on the EGFR pathway in the heart and tests whether tocotrienols may modify radiation-induced changes in this pathway. METHODS: Male Sprague-Dawley rats received image-guided localized heart irradiation with 21 Gy. Twenty four hours before irradiation, rats received a single dose of tocotrienol-enriched formulation or vehicle by oral gavage. At time points from 2 h to 9 months after irradiation, left ventricular expression of EGFR pathway mediators was studied. RESULTS: Irradiation caused a decrease in the expression of epidermal growth factor (EGF) and neuregulin-1 (Nrg-1) mRNA from 6 h up to 10 weeks, followed by an upregulation of these ligands and the receptor erythroblastic leukemia viral oncogene homolog (ErbB)4 at 6 months. In addition, the upregulation of Nrg-1 was statistically significant up to 9 months after irradiation. A long-term upregulation of ErbB2 protein did not coincide with changes in transcription or post-translational interaction with the chaperone heat shock protein 90 (HSP90). Pretreatment with tocotrienols prevented radiation-induced changes at 2 weeks. CONCLUSIONS: Local heart irradiation causes long-term changes in the EGFR pathway. Studies have to address how radiation may interact with cardiotoxic effects of EGFR inhibitors.
Authors: Sonyo Shin-Kang; Victoria P Ramsauer; Janet Lightner; Kanishka Chakraborty; William Stone; Sharon Campbell; Shrikanth A G Reddy; Koyamangalath Krishnan Journal: Free Radic Biol Med Date: 2011-06-21 Impact factor: 7.376
Authors: Xiang Hong Li; Dadin Fu; Nabil H Latif; Conor P Mullaney; Patrick H Ney; Steven R Mog; Mark H Whitnall; Venkataraman Srinivasan; Mang Xiao Journal: Haematologica Date: 2010-09-07 Impact factor: 9.941
Authors: Shilpa Kulkarni; Sanchita P Ghosh; Merriline Satyamitra; Steven Mog; Kevin Hieber; Lyudmila Romanyukha; Kristen Gambles; Raymond Toles; Tzu-Cheg Kao; Martin Hauer-Jensen; K Sree Kumar Journal: Radiat Res Date: 2010-06 Impact factor: 2.841
Authors: Sunil Sharma; Ganesh Narayanasamy; Beata Przybyla; Jessica Webber; Marjan Boerma; Richard Clarkson; Eduardo G Moros; Peter M Corry; Robert J Griffin Journal: Technol Cancer Res Treat Date: 2016-07-08
Authors: Benjamin J Lieblong; Vijayalakshmi Sridharan; Anup K Srivastava; Eduardo G Moros; Sunil K Sharma; Marjan Boerma Journal: Int J Radiat Biol Date: 2015-06-19 Impact factor: 2.694
Authors: Vijayalakshmi Sridharan; Preeti Tripathi; Sunil Sharma; Peter M Corry; Eduardo G Moros; Awantika Singh; Cesar M Compadre; Martin Hauer-Jensen; Marjan Boerma Journal: PLoS One Date: 2013-07-22 Impact factor: 3.240
Authors: Ingar Seemann; Johannes A M te Poele; Ji-Ying Song; Saske Hoving; Nicola S Russell; Fiona A Stewart Journal: Breast Cancer Res Treat Date: 2013-10-04 Impact factor: 4.872
Authors: Rachel A Schlaak; Anne Frei; Gopika SenthilKumar; Shirng-Wern Tsaih; Clive Wells; Jyotsna Mishra; Michael J Flister; Amadou K S Camara; Carmen Bergom Journal: Front Cardiovasc Med Date: 2020-03-05